Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
OmniAb Inc.
OABICurrent price
4.07 USD
0 USD (0.00%)
Last closed
4.07 USD
Company
–
ISIN
US68218J1034
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
534 096 768 USD
Yield for 12 month
-12.28 %
1Y
3Y
5Y
10Y
15Y
OABI
OmniAb, Inc., a biotechnology company, engages in the discovery and provision of therapeutic antibody discovery technologies in the United States. The company's technology platform creates and screens diverse antibody repertoires and identify optimal antibodies for partners' drug development efforts. Its OmniAb platform is the biological intelligence of proprietary transgenic animals, including OmniRat, OmniChicken, and OmniMouse that have been genetically modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. The company's OmniFlic, a bispecific rat, and OmniClic, a bispecific chicken, designed for discovery of bispecific antibody applications; OmniTaur, which provides unique structural characteristics of cow antibodies for complex targets; and OmniDeep, a suite of in silico, an AI and machine learning tools for therapeutic discovery and optimization through various technologies and capabilities. OmniAb, Inc. was founded in 2012 and is headquartered in Emeryville, California. Address: 5980 Horton Street, Emeryville, CA, United States, 94608
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9.75 USDP/E ratio
–Dividend Yield
–Current Year
+34 164 000 USD
Last Year
+59 077 000 USD
Current Quarter
+7 614 000 USD
Last Quarter
+3 801 000 USD
Current Year
+14 667 000 USD
Last Year
+42 827 000 USD
Current Quarter
+1 513 000 USD
Last Quarter
-1 148 000 USD
Key Figures OABI
1 year
3 years
5 years
10 years
EBITDA
-62 019 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-13.95 %
PEG Ratio
–
Return On Equity TTM
-19.87 %
Wall Street Target Price
9.75 USD
Revenue TTM
21 714 000 USD
Book Value
2.49 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
9.6 %
Dividend Yield
–
Gross Profit TTM
59 077 000 USD
Earnings per share
-0.62 USD
Diluted Eps TTM
-0.62 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-287.29 %
Dividend Analytics OABI
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History OABI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation OABI
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
23.0819
Price Sales TTM
24.5969
Enterprise Value EBITDA
-10.6179
Price Book MRQ
1.8155
Financials OABI
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators OABI
For 52 weeks
3.56 USD
6.72 USD
50 Day MA
4.17 USD
Shares Short Prior Month
8 244 808
200 Day MA
4.64 USD
Short Ratio
24.68
Shares Short
8 341 587
Short Percent
7.79 %
BeatStart